BioSyent Inc. is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical products that have been successfully developed, are proven safe and effective, and have track records of improving the lives of patients.
The Venture 50™ is a ranking of the top performers on TSX Venture Exchange over the last year. The ranking is composed of 10 companies from each of five industry sectors, selected based on three equally-weighted criteria of market capitalization growth, share price appreciation, and trading value.
For the full 2024 Venture 50 list, ranking methodology, and more, visit www.tsx.com/venture50
